Abstract
Background:Plexiform neurofibromas are benign neoplasms that develop in 20-50% children with neurofibromatosis type 1 (NF1). Selumetinib was approved ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
